GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Total Assets

Fisher & Paykel Healthcare (NZSE:FPH) Total Assets : NZ$2,390 Mil (As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Total Assets?

Fisher & Paykel Healthcare's Total Assets for the quarter that ended in Sep. 2023 was NZ$2,390 Mil.

Warning Sign:

If a company builds assets at 19.1% a year, faster than its revenue growth rate of 12.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Fisher & Paykel Healthcare's average Total Assets Growth Rate was 14.60% per year. During the past 3 years, the average Total Assets Growth Rate was 17.30% per year. During the past 5 years, the average Total Assets Growth Rate was 19.10% per year. During the past 10 years, the average Total Assets Growth Rate was 14.20% per year.

During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average Total Assets Growth Rate was 23.90%. The lowest was 5.10%. And the median was 12.00%.

Total Assets is connected with ROA %. Fisher & Paykel Healthcare's annualized ROA % for the quarter that ended in Sep. 2023 was 9.34%. Total Assets is also linked to Revenue through Asset Turnover. Fisher & Paykel Healthcare's Asset Turnover for the quarter that ended in Sep. 2023 was 0.36.


Fisher & Paykel Healthcare Total Assets Historical Data

The historical data trend for Fisher & Paykel Healthcare's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Total Assets Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,206.70 1,435.00 2,075.00 2,107.00 2,204.50

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,045.40 2,107.00 2,094.50 2,204.50 2,389.80

Fisher & Paykel Healthcare Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Fisher & Paykel Healthcare's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (A: Mar. 2023 )+Total Liabilities (A: Mar. 2023 )
=1753.4+451.1
=2,205

Fisher & Paykel Healthcare's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets=Total Equity (Q: Sep. 2023 )+Total Liabilities (Q: Sep. 2023 )
=1751.8+638
=2,390

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) Total Assets Explanation

Total Assets is connected with ROA %.

Fisher & Paykel Healthcare's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=214.6/( (2204.5+2389.8)/ 2 )
=214.6/2297.15
=9.34 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Fisher & Paykel Healthcare's Asset Turnover for the quarter that ended in Sep. 2023 is

Asset Turnover
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=815.8/( (2204.5+2389.8)/ 2 )
=815.8/2297.15
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Fisher & Paykel Healthcare Total Assets Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.